Hiscox (LON:HSX - Get Free Report)'s stock had its "overweight" rating reiterated by analysts at JPMorgan Chase & Co. in a research note issued to investors on Friday, MarketBeat Ratings reports.
A number of other brokerages also recently weighed in on HSX. Berenberg Bank reaffirmed a "buy" rating and set a GBX 1,450 ($19.15) price target on shares of Hiscox in a report on Friday, July 25th. Royal Bank Of Canada lifted their target price on shares of Hiscox from GBX 1,125 ($14.86) to GBX 1,300 ($17.17) and gave the stock a "sector perform" rating in a research note on Friday, July 18th. Finally, Peel Hunt reaffirmed a "buy" rating and issued a GBX 1,460 ($19.29) price objective on shares of Hiscox in a research note on Thursday, July 3rd.
Read Our Latest Report on Hiscox
Hiscox Stock Down 1.7%
Shares of HSX stock opened at GBX 1,270 ($16.78) on Friday. Hiscox has a 52 week low of GBX 1,008 ($13.32) and a 52 week high of GBX 1,360 ($17.97). The company has a market cap of £5.47 billion, a P/E ratio of 7.79, a PEG ratio of -2.30 and a beta of 0.65. The business has a 50 day moving average of GBX 1,275.24 and a two-hundred day moving average of GBX 1,177.05.
About Hiscox
(
Get Free Report)
Hiscox Ltd, through its subsidiaries, provides insurance and reinsurance services in the United Kingdom, Europe, the United States, and internationally. The company operates through four segments: Hiscox Retail, Hiscox London Market, Hiscox Re & ILS, and Corporate Centre. It offers commercial insurance for small-and medium-sized businesses; and personal lines cover, including high-value household, fine art, and luxury motor, as well as artwork, antiques, classic cars, jewelry, collectables, and other assets through brokers, partners, and direct-to-consumers.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hiscox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hiscox wasn't on the list.
While Hiscox currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.